Appeal 2007-2208 Application 10/650,510 incorporating that patent by reference as describing a catalyst support for use therein. See, e.g., Zoeller ‘043, col. 3, ll. 53-65 and col. 6, ll. 2-5 and Zoeller ‘673, col. 4, ll. 48-64 and col. 5, ll. 22-30). Rather, Appellants make the same arguments concerning the particle size as made against the Examiner’s rejection of representative claim 1. For the reasons discussed above, we are not persuaded by these particle size arguments. Moreover, Appellants refer to Comparative Example 1 of their Specification and argue that the claimed catalyst particles possess unexpectedly improved fluidization properties in comparison with Amberesorb 572, a particle disclosed in the Zoeller patents, that was tested in this Comparative Example (Specification ¶ 0072). However, Specification comparative Example 1 discloses or reports nothing concerning unexpected results for the claimed particles. Rather, the Comparative Example 1 merely shows that Ambersorb 572 particles were loaded with glass frit in a small glass tube and fluidization was achieved at a gas hourly space velocity of 7500 hr-1. The question as to whether unexpected advantages have been demonstrated is a factual question. In re Johnson, 747 F.2d 1456, 1460, 223 USPQ 1260, 1263 (Fed. Cir. 1984). Thus, it is incumbent upon Appellants to supply the factual basis to rebut the prima facie case of obviousness established by the examiner. See, e.g., In re Klosak, 455 F.2d 1077, 1080, 173 USPQ 14, 16 (CCPA 1972). Here, the Appellants cursory reference to Comparative Example 1 of the Specification is clearly inadequate to satisfy Appellants’ burden to demonstrate unexpected results that are commensurate in scope with the claimed invention. 7Page: Previous 1 2 3 4 5 6 7 8 Next
Last modified: September 9, 2013